{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T16:40:03Z","timestamp":1746463203033,"version":"3.40.4"},"posted":{"date-parts":[[2025,4,14]]},"group-title":"In Review","reference-count":49,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,12,17]]},"abstract":"<title>Abstract<\/title>\n        <p>Background and Objectives\n Ataxin-1 (ATXN1) is a protein in which expansion of its polyglutamine tract causes the neurodegenerative disorder spinocerebellar ataxia type 1 (SCA1) via a gain-of-function. Wild type ATXN1 was recently shown to have a protective role in regulating severity of experimental autoimmune encephalomyelitis (EAE), a well-established mouse model for Multiple sclerosis (MS). This study further investigates the role of ATXN1 with an expanded polyglutamine tract in the context of MS using an EAE mouse model.\nMethods\n Hemizygous <italic>Atxn1 (Atxn1<\/italic><sup><italic>2Q\/\u2212<\/italic><\/sup>) mice or <italic>f<\/italic>-<italic>ATXN1<\/italic><sup><italic>146Q\/2Q<\/italic><\/sup>, heterozygous mice that have one copy of the endogenous mouse gene replaced with a polyQ expanded pathogenic human <italic>ATXN1<\/italic> gene, were injected with myelin oligodendrocytes glycoprotein (MOG<sub>35\u2009\u2212\u200955<\/sub>) peptide to induce EAE. Immunohistochemical and biochemical approaches were used to analyze the degree of demyelination, cell loss, axonal degeneration as well as detecting the activated immune cells and inflammatory cytokines upon EAE induction in <italic>Atxn1<\/italic><sup><italic>2Q\/\u2212<\/italic><\/sup> and <italic>f<\/italic>-<italic>ATXN1<\/italic><sup><italic>146Q\/2Q<\/italic><\/sup> mice.\nResults\n Our findings reveal that a loss-of-function of wild type <italic>Atxn1<\/italic> in <italic>Atxn1<\/italic><sup><italic>2Q\/\u2212<\/italic><\/sup> and <italic>f-ATXN1<\/italic><sup><italic>146Q\/2Q<\/italic><\/sup> mice significantly exacerbates the EAE symptoms, leading to increased demyelination, oligodendrocytes loss, heightened axon degeneration, and greater clinical disability in affected mice. Importantly, the data reveals that neurotoxic astrocytes are activated at acute stage of disease (PID-14) and at the chronic stage of disease (PID-30) neurotoxic astrocytes no longer show signs of activation. The data also demonstrated enhanced infiltration of immune cells into the lesions of mutant mice.\nDiscussion\n These results indicate that ATXN1 plays a protective role in modulating immune responses and maintaining neural integrity during MS. Importantly, expansion of the polyQ tract in ATXN1 results in a loss-of-function in ATXN1\u2019s ability to dampen the immune response. Understanding the functional role of ATXN1 in MS pathogenesis may open new avenues for therapeutic strategies aimed at mitigating disease progression.<\/p>","DOI":"10.21203\/rs.3.rs-5664390\/v1","type":"posted-content","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T15:21:06Z","timestamp":1744644066000},"source":"Crossref","is-referenced-by-count":0,"title":["An expanded polyglutamine in ATAXIN1 results in a loss-of-function that exacerbates severity of Multiple Sclerosis in an EAE mouse model"],"prefix":"10.21203","author":[{"given":"Gourango","family":"Talukdar","sequence":"first","affiliation":[{"name":"University of Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Duvick","sequence":"additional","affiliation":[{"name":"University of Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praseuth","family":"Yang","sequence":"additional","affiliation":[{"name":"University of Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brennon","family":"O\u2019Callaghan","sequence":"additional","affiliation":[{"name":"University of Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin J.","family":"Fuchs","sequence":"additional","affiliation":[{"name":"University of Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija","family":"Cvetanovic","sequence":"additional","affiliation":[{"name":"University of Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry T.","family":"Orr","sequence":"additional","affiliation":[{"name":"University of Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"author":"Klement IA","key":"ref1","unstructured":"Klement IA, Skinner PJ, Kaytor MD et al. Ataxin-1 Nuclear Localization and Aggregation: Role in Polyglutamine-Induced Disease in SCA1 Transgenic Mice."},{"issue":"3","key":"ref2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ng0793-221","article-title":"Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1","volume":"4","author":"Orr HT","year":"1993","unstructured":"Orr HT, Chung M, yi, Banfi S, et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet. 1993;4(3):221\u20136. 10.1038\/ng0793-221.","journal-title":"Nat Genet"},{"issue":"15","key":"ref3","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1002\/mds.22288","article-title":"Early symptoms in spinocerebellar ataxia type 1, 2, 3, and 6","volume":"23","author":"Globas C","year":"2008","unstructured":"Globas C, Du Montcel ST, Baliko L, et al. Early symptoms in spinocerebellar ataxia type 1, 2, 3, and 6. Mov Disord. 2008;23(15):2232\u20138. 10.1002\/mds.22288.","journal-title":"Mov Disord"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3389\/fphar.2019.01008","article-title":"Neuroinflammation as a Common Feature of Neurodegenerative Disorders","volume":"10","author":"Guzman-Martinez L","year":"2019","unstructured":"Guzman-Martinez L, Maccioni RB, Andrade V, Navarrete LP, Pastor MG, Ramos-Escobar N. Neuroinflammation as a Common Feature of Neurodegenerative Disorders. Front Pharmacol. 2019;10:1008. 10.3389\/fphar.2019.01008.","journal-title":"Front Pharmacol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.neuroscience.2015.01.003","article-title":"Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1","volume":"289","author":"Cvetanovic M","year":"2015","unstructured":"Cvetanovic M, Ingram M, Orr H, Opal P. Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1. Neuroscience. 2015;289:289\u201399. 10.1016\/j.neuroscience.2015.01.003.","journal-title":"Neuroscience"},{"issue":"23","key":"ref6","doi-asserted-by":"publisher","first-page":"23619","DOI":"10.18632\/aging.103700","article-title":"Pathomechanism characterization and potential therapeutics identification for SCA3 targeting neuroinflammation","volume":"12","author":"Chiu YJ","year":"2020","unstructured":"Chiu YJ, Lin SA, Chen WL, et al. Pathomechanism characterization and potential therapeutics identification for SCA3 targeting neuroinflammation. Aging. 2020;12(23):23619\u201346. 10.18632\/aging.103700.","journal-title":"Aging"},{"issue":"38","key":"ref7","doi-asserted-by":"publisher","first-page":"23742","DOI":"10.1073\/pnas.2003798117","article-title":"Ataxin-1 regulates B cell function and the severity of autoimmune experimental encephalomyelitis","volume":"117","author":"Didonna A","year":"2020","unstructured":"Didonna A, Canto Puig E, Ma Q, et al. Ataxin-1 regulates B cell function and the severity of autoimmune experimental encephalomyelitis. Proc Natl Acad Sci USA. 2020;117(38):23742\u201350. 10.1073\/pnas.2003798117.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"ref8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13041-020-00715-0","article-title":"The novel multiple sclerosis susceptibility gene ATXN1 regulates B cell receptor signaling in B-1a cells","volume":"14","author":"Ma Q","year":"2021","unstructured":"Ma Q, Didonna A. The novel multiple sclerosis susceptibility gene ATXN1 regulates B cell receptor signaling in B-1a cells. Mol Brain. 2021;14(1):19. 10.1186\/s13041-020-00715-0.","journal-title":"Mol Brain"},{"issue":"4","key":"ref9","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/imcb.12622","article-title":"Ataxin-1 controls the expression of specific noncoding RNAs in B cells upon autoimmune demyelination","volume":"101","author":"Ma Q","year":"2023","unstructured":"Ma Q, Didonna A. Ataxin-1 controls the expression of specific noncoding RNAs in B cells upon autoimmune demyelination. Immunol Cell Biol. 2023;101(4):358\u201367. 10.1111\/imcb.12622.","journal-title":"Immunol Cell Biol"},{"issue":"8","key":"ref10","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/acn3.51618","article-title":"Epigenetic control of ataxin-1 in multiple sclerosis","volume":"9","author":"Ma Q","year":"2022","unstructured":"Ma Q, Oksenberg JR, Didonna A. Epigenetic control of ataxin-1 in multiple sclerosis. Ann Clin Transl Neurol. 2022;9(8):1186\u201394. 10.1002\/acn3.51618.","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"ref11","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/bph.12499","article-title":"Midkine and multiple sclerosis","volume":"171","author":"Takeuchi H","year":"2014","unstructured":"Takeuchi H. Midkine and multiple sclerosis. Br J Pharmacol. 2014;171(4):931\u20135. 10.1111\/bph.12499.","journal-title":"Br J Pharmacol"},{"issue":"9","key":"ref12","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1007\/s00415-006-0503-6","article-title":"Cortical atrophy is relevant in multiple sclerosis at clinical onset","volume":"254","author":"Calabrese M","year":"2007","unstructured":"Calabrese M, Atzori M, Bernardi V, et al. Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol. 2007;254(9):1212\u201320. 10.1007\/s00415-006-0503-6.","journal-title":"J Neurol"},{"issue":"16","key":"ref13","doi-asserted-by":"publisher","first-page":"6214","DOI":"10.1523\/JNEUROSCI.21-16-06214.2001","article-title":"Acute Neuronal Apoptosis in a Rat Model of Multiple Sclerosis","volume":"21","author":"Meyer R","year":"2001","unstructured":"Meyer R, Weissert R, Diem R, et al. Acute Neuronal Apoptosis in a Rat Model of Multiple Sclerosis. J Neurosci. 2001;21(16):6214\u201320. 10.1523\/JNEUROSCI.21-16-06214.2001.","journal-title":"J Neurosci"},{"issue":"12","key":"ref14","doi-asserted-by":"publisher","first-page":"4312","DOI":"10.3390\/ijms21124312","article-title":"Approved and Emerging Disease Modifying Therapies on Neurodegeneration in Multiple Sclerosis","volume":"21","author":"Bross M","year":"2020","unstructured":"Bross M, Hackett M, Bernitsas E. Approved and Emerging Disease Modifying Therapies on Neurodegeneration in Multiple Sclerosis. IJMS. 2020;21(12):4312. 10.3390\/ijms21124312.","journal-title":"IJMS"},{"issue":"23","key":"ref15","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1056\/NEJMoa1100648","article-title":"Inflammatory Cortical Demyelination in Early Multiple Sclerosis","volume":"365","author":"Lucchinetti CF","year":"2011","unstructured":"Lucchinetti CF, Popescu BFG, Bunyan RF, et al. Inflammatory Cortical Demyelination in Early Multiple Sclerosis. N Engl J Med. 2011;365(23):2188\u201397. 10.1056\/NEJMoa1100648.","journal-title":"N Engl J Med"},{"issue":"3","key":"ref16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11910-007-0036-0","article-title":"New concepts on progressive multiple sclerosis","volume":"7","author":"Lassmann H","year":"2007","unstructured":"Lassmann H. New concepts on progressive multiple sclerosis. Curr Neurol Neurosci Rep. 2007;7(3):239\u201344. 10.1007\/s11910-007-0036-0.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"3","key":"ref17","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1136\/jnnp.64.3.402","article-title":"Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis","volume":"64","author":"Lycke JN","year":"1998","unstructured":"Lycke JN, Karlsson JE, Andersen O, Rosengren LE. Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1998;64(3):402\u20134. 10.1136\/jnnp.64.3.402.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"ref18","doi-asserted-by":"publisher","first-page":"fcac284","DOI":"10.1093\/braincomms\/fcac284","article-title":"Alterations of the axon initial segment in multiple sclerosis grey matter","volume":"4","author":"Senol AD","year":"2022","unstructured":"Senol AD, Pinto G, Beau M, et al. Alterations of the axon initial segment in multiple sclerosis grey matter. Brain Commun. 2022;4(6):fcac284. 10.1093\/braincomms\/fcac284.","journal-title":"Brain Commun"},{"issue":"9","key":"ref19","doi-asserted-by":"publisher","first-page":"e176057","DOI":"10.1172\/jci.insight.176057","article-title":"Mapping SCA1 regional vulnerabilities reveals neural and skeletal muscle contributions to disease","volume":"9","author":"Duvick L","year":"2024","unstructured":"Duvick L, Southern WM, Benzow KA, et al. Mapping SCA1 regional vulnerabilities reveals neural and skeletal muscle contributions to disease. JCI Insight. 2024;9(9):e176057. 10.1172\/jci.insight.176057.","journal-title":"JCI Insight"},{"issue":"14","key":"ref20","doi-asserted-by":"publisher","first-page":"5508","DOI":"10.1523\/JNEUROSCI.18-14-05508.1998","article-title":"Mice Lacking Ataxin-1 Display Learning Deficits and Decreased Hippocampal Paired-Pulse Facilitation","volume":"18","author":"Matilla A","year":"1998","unstructured":"Matilla A, Roberson ED, Banfi S, et al. Mice Lacking Ataxin-1 Display Learning Deficits and Decreased Hippocampal Paired-Pulse Facilitation. J Neurosci. 1998;18(14):5508\u201316. 10.1523\/JNEUROSCI.18-14-05508.1998.","journal-title":"J Neurosci"},{"issue":"7","key":"ref21","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/glia.23307","article-title":"Activating transcription factor 6\u03b1 deficiency exacerbates oligodendrocyte death and myelin damage in immune-mediated demyelinating diseases","volume":"66","author":"Stone S","year":"2018","unstructured":"Stone S, Wu S, Jamison S, Durose W, Pallais JP, Lin W. Activating transcription factor 6\u03b1 deficiency exacerbates oligodendrocyte death and myelin damage in immune-mediated demyelinating diseases. Glia. 2018;66(7):1331\u201345. 10.1002\/glia.23307.","journal-title":"Glia"},{"issue":"33","key":"ref22","doi-asserted-by":"publisher","first-page":"6444","DOI":"10.1523\/JNEUROSCI.1156-20.2020","article-title":"NF-\u03baB Activation Accounts for the Cytoprotective Effects of PERK Activation on Oligodendrocytes during EAE","volume":"40","author":"Lei Z","year":"2020","unstructured":"Lei Z, Yue Y, Stone S, Wu S, Lin W. NF-\u03baB Activation Accounts for the Cytoprotective Effects of PERK Activation on Oligodendrocytes during EAE. J Neurosci. 2020;40(33):6444\u201356. 10.1523\/JNEUROSCI.1156-20.2020.","journal-title":"J Neurosci"},{"issue":"12","key":"ref23","doi-asserted-by":"publisher","first-page":"7425","DOI":"10.1074\/jbc.R800041200","article-title":"Pathogenic Mechanisms of a Polyglutamine-mediated Neurodegenerative Disease, Spinocerebellar Ataxia Type 1","volume":"284","author":"Zoghbi HY","year":"2009","unstructured":"Zoghbi HY, Orr HT. Pathogenic Mechanisms of a Polyglutamine-mediated Neurodegenerative Disease, Spinocerebellar Ataxia Type 1. J Biol Chem. 2009;284(12):7425\u20139. 10.1074\/jbc.R800041200.","journal-title":"J Biol Chem"},{"issue":"5","key":"ref24","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1007\/s11307-016-0944-y","article-title":"PET Imaging Study of S1PR1 Expression in a Rat Model of Multiple Sclerosis","volume":"18","author":"Liu H","year":"2016","unstructured":"Liu H, Jin H, Yue X, et al. PET Imaging Study of S1PR1 Expression in a Rat Model of Multiple Sclerosis. Mol Imaging Biol. 2016;18(5):724\u201332. 10.1007\/s11307-016-0944-y.","journal-title":"Mol Imaging Biol"},{"issue":"5","key":"ref25","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/glia.22634","article-title":"Genetic inactivation of PERK signaling in mouse oligodendrocytes: Normal developmental myelination with increased susceptibility to inflammatory demyelination: Oligodendrocyte-Specific PERK Inactivation","volume":"62","author":"Hussien Y","year":"2014","unstructured":"Hussien Y, Cavener DR, Popko B. Genetic inactivation of PERK signaling in mouse oligodendrocytes: Normal developmental myelination with increased susceptibility to inflammatory demyelination: Oligodendrocyte-Specific PERK Inactivation. Glia. 2014;62(5):680\u201391. 10.1002\/glia.22634.","journal-title":"Glia"},{"issue":"3","key":"ref26","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1007\/s12035-023-03618-y","article-title":"Inhibiting the NLRP3 Inflammasome with MCC950 Alleviates Neurological Impairment in the Brain of EAE Mice","volume":"61","author":"Hou B","year":"2024","unstructured":"Hou B, Yin J, Liu S, et al. Inhibiting the NLRP3 Inflammasome with MCC950 Alleviates Neurological Impairment in the Brain of EAE Mice. Mol Neurobiol. 2024;61(3):1318\u201330. 10.1007\/s12035-023-03618-y.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"ref27","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.exer.2008.05.017","article-title":"Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis","volume":"87","author":"Shindler KS","year":"2008","unstructured":"Shindler KS, Ventura E, Dutt M, Rostami A. Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis. Exp Eye Res. 2008;87(3):208\u201313. 10.1016\/j.exer.2008.05.017.","journal-title":"Exp Eye Res"},{"issue":"2","key":"ref28","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/brain\/awh032","article-title":"Co-localization of sodium channel Nav1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE","volume":"127","author":"Craner MJ","year":"2004","unstructured":"Craner MJ. Co-localization of sodium channel Nav1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE. Brain. 2004;127(2):294\u2013303. 10.1093\/brain\/awh032.","journal-title":"Brain"},{"issue":"5","key":"ref29","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1152\/jn.00434.2003","article-title":"Phenytoin Protects Spinal Cord Axons and Preserves Axonal Conduction and Neurological Function in a Model of Neuroinflammation In Vivo","volume":"90","author":"Lo AC","year":"2003","unstructured":"Lo AC, Saab CY, Black JA, Waxman SG. Phenytoin Protects Spinal Cord Axons and Preserves Axonal Conduction and Neurological Function in a Model of Neuroinflammation In Vivo. J Neurophysiol. 2003;90(5):3566\u201371. 10.1152\/jn.00434.2003.","journal-title":"J Neurophysiol"},{"issue":"3","key":"ref30","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/glia.22616","article-title":"Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination","volume":"62","author":"Brambilla R","year":"2014","unstructured":"Brambilla R, Morton PD, Ashbaugh JJ, Karmally S, Lambertsen KL, Bethea JR. Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination. Glia. 2014;62(3):452\u201367. 10.1002\/glia.22616.","journal-title":"Glia"},{"issue":"18","key":"ref31","doi-asserted-by":"publisher","first-page":"8416","DOI":"10.1073\/pnas.0910627107","article-title":"Estradiol inhibits ongoing autoimmune neuroinflammation and NF\u03baB-dependent CCL2 expression in reactive astrocytes","volume":"107","author":"Giraud SN","year":"2010","unstructured":"Giraud SN, Caron CM, Pham-Dinh D, Kitabgi P, Nicot AB. Estradiol inhibits ongoing autoimmune neuroinflammation and NF\u03baB-dependent CCL2 expression in reactive astrocytes. Proc Natl Acad Sci USA. 2010;107(18):8416\u201321. 10.1073\/pnas.0910627107.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"ref32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/eji.201242679","article-title":"Astrocytic F as ligand expression is required to induce T -cell apoptosis and recovery from experimental autoimmune encephalomyelitis","volume":"43","author":"Wang X","year":"2013","unstructured":"Wang X, Haroon F, Karray S, Martina Deckert, Schl\u00fcter D. Astrocytic F as ligand expression is required to induce T -cell apoptosis and recovery from experimental autoimmune encephalomyelitis. Eur J Immunol. 2013;43(1):115\u201324. 10.1002\/eji.201242679.","journal-title":"Eur J Immunol"},{"issue":"5","key":"ref33","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.ajpath.2016.01.004","article-title":"Deficiency of I\u03baB Kinase \u03b2 in Myeloid Cells Reduces Severity of Experimental Autoimmune Encephalomyelitis","volume":"186","author":"Hao W","year":"2016","unstructured":"Hao W, Decker Y, Schn\u00f6der L, et al. Deficiency of I\u03baB Kinase \u03b2 in Myeloid Cells Reduces Severity of Experimental Autoimmune Encephalomyelitis. Am J Pathol. 2016;186(5):1245\u201357. 10.1016\/j.ajpath.2016.01.004.","journal-title":"Am J Pathol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3389\/fimmu.2019.00710","article-title":"The iNOS Activity During an Immune Response Controls the CNS Pathology in Experimental Autoimmune Encephalomyelitis","volume":"10","author":"Sonar SA","year":"2019","unstructured":"Sonar SA, Lal G. The iNOS Activity During an Immune Response Controls the CNS Pathology in Experimental Autoimmune Encephalomyelitis. Front Immunol. 2019;10:710. 10.3389\/fimmu.2019.00710.","journal-title":"Front Immunol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2016.11.008","article-title":"Nitration of MOG diminishes its encephalitogenicity depending on MHC haplotype","volume":"303","author":"Warnecke A","year":"2017","unstructured":"Warnecke A, Musunuri S, N\u2019diaye M, et al. Nitration of MOG diminishes its encephalitogenicity depending on MHC haplotype. J Neuroimmunol. 2017;303:1\u201312. 10.1016\/j.jneuroim.2016.11.008.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"ref36","doi-asserted-by":"publisher","first-page":"8272","DOI":"10.1038\/srep08272","article-title":"Deficiency of Capicua disrupts bile acid homeostasis","volume":"5","author":"Kim E","year":"2015","unstructured":"Kim E, Park S, Choi N, et al. Deficiency of Capicua disrupts bile acid homeostasis. Sci Rep. 2015;5(1):8272. 10.1038\/srep08272.","journal-title":"Sci Rep"},{"issue":"1","key":"ref37","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/neup.12612","article-title":"Serum pro\u2010inflammatory and anti\u2010inflammatory cytokines and the pathogenesis of experimental autoimmune encephalomyelitis","volume":"40","author":"Jahan-Abad AJ","year":"2020","unstructured":"Jahan-Abad AJ, Karima S, Shateri S, et al. Serum pro\u2010inflammatory and anti\u2010inflammatory cytokines and the pathogenesis of experimental autoimmune encephalomyelitis. Neuropathology. 2020;40(1):84\u201392. 10.1111\/neup.12612.","journal-title":"Neuropathology"},{"issue":"2","key":"ref38","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1365-2990.2010.01122.x","article-title":"Fusion between human mesenchymal stem cells and rodent cerebellar Purkinje cells","volume":"37","author":"Kemp K","year":"2011","unstructured":"Kemp K, Gordon D, Wraith DC, et al. Fusion between human mesenchymal stem cells and rodent cerebellar Purkinje cells. Neuropathol Appl Neurobiol. 2011;37(2):166\u201378. 10.1111\/j.1365-2990.2010.01122.x.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"ref39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12974-016-0513-y","article-title":"Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis","volume":"13","author":"Valentin-Torres A","year":"2016","unstructured":"Valentin-Torres A, Savarin C, Hinton DR, Phares TW, Bergmann CC, Stohlman SA. Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis. J Neuroinflammation. 2016;13(1):46. 10.1186\/s12974-016-0513-y.","journal-title":"J Neuroinflammation"},{"issue":"4","key":"ref40","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s12015-010-9178-6","article-title":"Inflammatory Cytokine Induced Regulation of Superoxide Dismutase 3 Expression by Human Mesenchymal Stem Cells","volume":"6","author":"Kemp K","year":"2010","unstructured":"Kemp K, Gray E, Mallam E, Scolding N, Wilkins A. Inflammatory Cytokine Induced Regulation of Superoxide Dismutase 3 Expression by Human Mesenchymal Stem Cells. Stem Cell Rev Rep. 2010;6(4):548\u201359. 10.1007\/s12015-010-9178-6.","journal-title":"Stem Cell Rev Rep"},{"issue":"4","key":"ref41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/scrt228","article-title":"Effective combination of human bone marrow mesenchymal stem cells and minocycline in experimental autoimmune encephalomyelitis mice","volume":"4","author":"Hou Y","year":"2013","unstructured":"Hou Y, Ryu CH, Park KY, Kim SM, Jeong CH, Jeun SS. Effective combination of human bone marrow mesenchymal stem cells and minocycline in experimental autoimmune encephalomyelitis mice. Stem Cell Res Ther. 2013;4(4):77. 10.1186\/scrt228.","journal-title":"Stem Cell Res Ther"},{"issue":"1\u20132","key":"ref42","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jns.2014.02.039","article-title":"Cytokine production profiles in chronic relapsing\u2013remitting experimental autoimmune encephalomyelitis: IFN-\u03b3 and TNF-\u03b1 are important participants in the first attack but not in the relapse","volume":"340","author":"Hidaka Y","year":"2014","unstructured":"Hidaka Y, Inaba Y, Matsuda K, et al. Cytokine production profiles in chronic relapsing\u2013remitting experimental autoimmune encephalomyelitis: IFN-\u03b3 and TNF-\u03b1 are important participants in the first attack but not in the relapse. J Neurol Sci. 2014;340(1\u20132):117\u201322. 10.1016\/j.jns.2014.02.039.","journal-title":"J Neurol Sci"},{"issue":"20","key":"ref43","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.3390\/cells11203323","article-title":"Spatial and Temporal Diversity of Astrocyte Phenotypes in Spinocerebellar Ataxia Type 1 Mice","volume":"11","author":"Rosa JG","year":"2022","unstructured":"Rosa JG, Hamel K, Sheeler C, et al. Spatial and Temporal Diversity of Astrocyte Phenotypes in Spinocerebellar Ataxia Type 1 Mice. Cells. 2022;11(20):3323. 10.3390\/cells11203323.","journal-title":"Cells"},{"issue":"1","key":"ref44","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/2051-5960-1-70","article-title":"Astrocytes differentially respond to inflammatory autoimmune insults and imbalances of neural activity","volume":"1","author":"Jukkola P","year":"2013","unstructured":"Jukkola P, Guerrero T, Gray V, Gu C. Astrocytes differentially respond to inflammatory autoimmune insults and imbalances of neural activity. acta neuropathol commun. 2013;1(1):70. 10.1186\/2051-5960-1-70.","journal-title":"acta neuropathol commun"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"104892","DOI":"10.1016\/j.msard.2023.104892","article-title":"Modelling MOG antibody-associated disorder and neuromyelitis optica spectrum disorder in animal models: Spinal cord manifestations","volume":"78","author":"Remlinger J","year":"2023","unstructured":"Remlinger J, Bagnoud M, Meli I, et al. Modelling MOG antibody-associated disorder and neuromyelitis optica spectrum disorder in animal models: Spinal cord manifestations. Multiple Scler Relat Disorders. 2023;78:104892. 10.1016\/j.msard.2023.104892.","journal-title":"Multiple Scler Relat Disorders"},{"issue":"37","key":"ref46","doi-asserted-by":"publisher","first-page":"11511","DOI":"10.1523\/JNEUROSCI.1514-09.2009","article-title":"Reactive Astrocytes Form Scar-Like Perivascular Barriers to Leukocytes during Adaptive Immune Inflammation of the CNS","volume":"29","author":"Voskuhl RR","year":"2009","unstructured":"Voskuhl RR, Peterson RS, Song B, et al. Reactive Astrocytes Form Scar-Like Perivascular Barriers to Leukocytes during Adaptive Immune Inflammation of the CNS. J Neurosci. 2009;29(37):11511\u201322. 10.1523\/JNEUROSCI.1514-09.2009.","journal-title":"J Neurosci"},{"issue":"4","key":"ref47","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3390\/jcm10040857","article-title":"Dimethyl Fumarate Suppresses Demyelination and Axonal Loss through Reduction in Pro-Inflammatory Macrophage-Induced Reactive Astrocytes and Complement C3 Deposition","volume":"10","author":"Yadav SK","year":"2021","unstructured":"Yadav SK, Ito N, Soin D, Ito K, Dhib-Jalbut S. Dimethyl Fumarate Suppresses Demyelination and Axonal Loss through Reduction in Pro-Inflammatory Macrophage-Induced Reactive Astrocytes and Complement C3 Deposition. JCM. 2021;10(4):857. 10.3390\/jcm10040857.","journal-title":"JCM"},{"issue":"10","key":"ref48","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm.3681","article-title":"Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation","volume":"20","author":"Mayo L","year":"2014","unstructured":"Mayo L, Trauger SA, Blain M, et al. Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. Nat Med. 2014;20(10):1147\u201356. 10.1038\/nm.3681.","journal-title":"Nat Med"},{"issue":"1","key":"ref49","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12974-017-0880-z","article-title":"Inhibition of colony-stimulating factor 1 receptor early in disease ameliorates motor deficits in SCA1 mice","volume":"14","author":"Qu W","year":"2017","unstructured":"Qu W, Johnson A, Kim JH, Lukowicz A, Svedberg D, Cvetanovic M. Inhibition of colony-stimulating factor 1 receptor early in disease ameliorates motor deficits in SCA1 mice. J Neuroinflammation. 2017;14(1):107. 10.1186\/s12974-017-0880-z.","journal-title":"J Neuroinflammation"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5664390\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5664390\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T16:04:38Z","timestamp":1746461078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5664390\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":49,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-5664390\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s12974-025-03450-2","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,4,14]]},"subtype":"preprint"}}